scPharmaceuticals Inc. (SCPH) Tops Q4 EPS by 7c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.47 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance